US Stock MarketDetailed Quotes

Revelation Biosciences (REVB)

Watchlist
  • 1.040
  • +0.062+6.31%
Close May 12 15:59 ET
  • 1.020
  • -0.020-1.88%
Pre 07:21 ET
4.06MMarket Cap-0.79P/E (TTM)

Revelation Biosciences (REVB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-15.05%-3.21M
54.86%-8.27M
47.51%-1.97M
82.84%-1.59M
22.57%-1.92M
1.53%-2.79M
-151.45%-18.32M
-87.12%-3.75M
-439.24%-9.26M
-24.46%-2.48M
Net income from continuing operations
-46.71%-3.01M
40.73%-8.91M
-45.50%-2.51M
14.92%-1.91M
70.86%-2.44M
23.51%-2.05M
-12,405.64%-15.04M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
Operating gains losses
----
111.11%9.05K
96.60%-87
275.40%10.6K
99.03%-43
97.93%-1.42K
99.02%-81.44K
96.25%-2.56K
93.47%-6.04K
98.96%-4.42K
Depreciation and amortization
-0.25%7.2K
-3.10%27.06K
-18.96%5.85K
-6.30%6.77K
0.00%7.22K
15.31%7.22K
11.47%27.92K
15.31%7.22K
15.30%7.22K
15.30%7.22K
Other non cash items
728.73%55.7K
-25.48%18.63K
----
----
--0
--6.72K
--25K
--0
--0
----
Change In working capital
24.47%-739.7K
99.82%-6.04K
107.12%149.45K
104.35%306.76K
-91.16%517.05K
-674.37%-979.3K
-448.53%-3.42M
-1,013.02%-2.1M
-829.76%-7.05M
3,247.47%5.85M
-Change in prepaid assets
74.90%-39.3K
-347.88%-44.6K
-75.29%12.64K
686.56%62.12K
169.10%37.22K
-1,321.78%-156.57K
255.65%17.99K
-24.72%51.15K
-91.89%7.9K
-165.39%-53.87K
-Change in payables and accrued expense
13.38%-712.66K
101.81%63.64K
107.53%161.89K
103.47%244.65K
-91.87%479.83K
-291.01%-822.73K
-485.27%-3.51M
-1,624.50%-2.15M
-912.48%-7.06M
2,301.11%5.91M
-Change in other current assets
----
---30.94K
----
----
----
----
--0
----
----
----
-Change in other current liabilities
--12.26K
--5.87K
----
----
----
--0
--0
----
----
----
-Change in other working capital
----
----
----
----
----
----
-13.33%71.13K
--0
--0
--0
Cash from discontinued investing activities
Operating cash flow
-15.05%-3.21M
54.86%-8.27M
47.51%-1.97M
82.84%-1.59M
22.57%-1.92M
1.53%-2.79M
-151.45%-18.32M
-87.12%-3.75M
-439.24%-9.26M
-24.46%-2.48M
Investing cash flow
Cash flow from continuing investing activities
-71.88K
0
0
0
0
0
-19.17K
17.69K
-17.69K
0
Net PPE purchase and sale
---71.88K
--0
--0
--0
--0
--0
---19.17K
--17.69K
---17.69K
--0
Cash from discontinued investing activities
Investing cash flow
---71.88K
--0
--0
--0
--0
--0
---19.17K
--17.69K
---17.69K
--0
Financing cash flow
Cash flow from continuing financing activities
6.7M
-2.93%12.47M
-101.12%-41.17K
143.77%9.12M
3.39M
0
-8.39%12.85M
3.69M
3.74M
0
Net common stock issuance
----
-37.45%3.39M
--0
--0
--3.39M
--0
-61.39%5.42M
--0
--0
--0
Net preferred stock issuance
----
----
----
----
----
----
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--6.7M
22.23%9.08M
-101.12%-41.17K
143.77%9.12M
--297
--0
21,854,932.35%7.43M
--3.69M
--3.74M
--0
Cash from discontinued financing activities
Financing cash flow
--6.7M
-2.93%12.47M
-101.12%-41.17K
143.77%9.12M
--3.39M
--0
-8.39%12.85M
--3.69M
--3.74M
--0
Net cash flow
Beginning cash position
64.65%10.7M
-45.80%6.5M
94.29%12.71M
-57.15%5.17M
-74.54%3.7M
-45.80%6.5M
128.28%11.99M
-53.26%6.54M
-23.16%12.07M
-17.80%14.55M
Current changes in cash
222.14%3.41M
176.49%4.2M
-4,677.46%-2.01M
236.20%7.53M
159.28%1.47M
-209.15%-2.79M
-181.51%-5.49M
97.90%-42.03K
-222.25%-5.53M
-24.46%-2.48M
End cash Position
280.97%14.11M
64.65%10.7M
64.65%10.7M
94.29%12.71M
-57.15%5.17M
-74.54%3.7M
-45.80%6.5M
-45.80%6.5M
-53.26%6.54M
-23.16%12.07M
Free cash flow
-17.62%-3.29M
54.91%-8.27M
47.26%-1.97M
82.87%-1.59M
22.57%-1.92M
2.20%-2.79M
-151.71%-18.34M
-86.23%-3.73M
-440.27%-9.27M
-24.46%-2.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -15.05%-3.21M54.86%-8.27M47.51%-1.97M82.84%-1.59M22.57%-1.92M1.53%-2.79M-151.45%-18.32M-87.12%-3.75M-439.24%-9.26M-24.46%-2.48M
Net income from continuing operations -46.71%-3.01M40.73%-8.91M-45.50%-2.51M14.92%-1.91M70.86%-2.44M23.51%-2.05M-12,405.64%-15.04M21.66%-1.73M14.72%-2.24M-479.34%-8.39M
Operating gains losses ----111.11%9.05K96.60%-87275.40%10.6K99.03%-4397.93%-1.42K99.02%-81.44K96.25%-2.56K93.47%-6.04K98.96%-4.42K
Depreciation and amortization -0.25%7.2K-3.10%27.06K-18.96%5.85K-6.30%6.77K0.00%7.22K15.31%7.22K11.47%27.92K15.31%7.22K15.30%7.22K15.30%7.22K
Other non cash items 728.73%55.7K-25.48%18.63K----------0--6.72K--25K--0--0----
Change In working capital 24.47%-739.7K99.82%-6.04K107.12%149.45K104.35%306.76K-91.16%517.05K-674.37%-979.3K-448.53%-3.42M-1,013.02%-2.1M-829.76%-7.05M3,247.47%5.85M
-Change in prepaid assets 74.90%-39.3K-347.88%-44.6K-75.29%12.64K686.56%62.12K169.10%37.22K-1,321.78%-156.57K255.65%17.99K-24.72%51.15K-91.89%7.9K-165.39%-53.87K
-Change in payables and accrued expense 13.38%-712.66K101.81%63.64K107.53%161.89K103.47%244.65K-91.87%479.83K-291.01%-822.73K-485.27%-3.51M-1,624.50%-2.15M-912.48%-7.06M2,301.11%5.91M
-Change in other current assets -------30.94K------------------0------------
-Change in other current liabilities --12.26K--5.87K--------------0--0------------
-Change in other working capital -------------------------13.33%71.13K--0--0--0
Cash from discontinued investing activities
Operating cash flow -15.05%-3.21M54.86%-8.27M47.51%-1.97M82.84%-1.59M22.57%-1.92M1.53%-2.79M-151.45%-18.32M-87.12%-3.75M-439.24%-9.26M-24.46%-2.48M
Investing cash flow
Cash flow from continuing investing activities -71.88K00000-19.17K17.69K-17.69K0
Net PPE purchase and sale ---71.88K--0--0--0--0--0---19.17K--17.69K---17.69K--0
Cash from discontinued investing activities
Investing cash flow ---71.88K--0--0--0--0--0---19.17K--17.69K---17.69K--0
Financing cash flow
Cash flow from continuing financing activities 6.7M-2.93%12.47M-101.12%-41.17K143.77%9.12M3.39M0-8.39%12.85M3.69M3.74M0
Net common stock issuance -----37.45%3.39M--0--0--3.39M--0-61.39%5.42M--0--0--0
Net preferred stock issuance --------------------------0--0--0--0
Proceeds from stock option exercised by employees --6.7M22.23%9.08M-101.12%-41.17K143.77%9.12M--297--021,854,932.35%7.43M--3.69M--3.74M--0
Cash from discontinued financing activities
Financing cash flow --6.7M-2.93%12.47M-101.12%-41.17K143.77%9.12M--3.39M--0-8.39%12.85M--3.69M--3.74M--0
Net cash flow
Beginning cash position 64.65%10.7M-45.80%6.5M94.29%12.71M-57.15%5.17M-74.54%3.7M-45.80%6.5M128.28%11.99M-53.26%6.54M-23.16%12.07M-17.80%14.55M
Current changes in cash 222.14%3.41M176.49%4.2M-4,677.46%-2.01M236.20%7.53M159.28%1.47M-209.15%-2.79M-181.51%-5.49M97.90%-42.03K-222.25%-5.53M-24.46%-2.48M
End cash Position 280.97%14.11M64.65%10.7M64.65%10.7M94.29%12.71M-57.15%5.17M-74.54%3.7M-45.80%6.5M-45.80%6.5M-53.26%6.54M-23.16%12.07M
Free cash flow -17.62%-3.29M54.91%-8.27M47.26%-1.97M82.87%-1.59M22.57%-1.92M2.20%-2.79M-151.71%-18.34M-86.23%-3.73M-440.27%-9.27M-24.46%-2.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More